(R)-1-((Benzyloxy)carbonyl)-3-methylpyrrolidine-3-carboxylic acid, 97%, 1g

1-Boc-2-Methoxypyrrolidine, 95.0%, 5g

1-[(3R)-Piperidin-3-yl]pyrrolidin-2-one hydrochloride, 1g

2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

5-BROMO-2,3-DIHYDROQUINOLIN-4(1H)-ONE, 95.0%, 100mg

2-Methylfuran, min. 99%, for synthesis, 500 ml, glass packaging

2-CHLORO-4-FLUORO-3-METHYL-5-NITROBENZOIC ACID, 95.0%, 1g

8-(4-Fluoro-2-nitrophenyl)-1,4-dioxa-8-azaspiro[4.5]decane, 1g

(S)-METHYL 3-(CBZ-AMINO)-5-METHYLHEXANOATE, 97.0%, 250mg

3-(2,4-dimethylphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one, 98%, 250mg

1-Benzyl-5-oxopyrrolidine-3-carboxamide, 97.0%, 5g

AEBSF Protease Inhibitor 100g

2-Bromo-3,4-difluoroanisole, 95.0%, 250mg